<div id="readability-page-1" class="page"><div> <div> , /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ImmunityBio, Inc. (&#34;ImmunityBio&#34; or the &#34;Company&#34;) (NASDAQ: IBRX). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN IMMUNITYBIO, INC. (IBRX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MAY 26, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com. What Is The Lawsuit About? The complaint filed alleges that, between January 19, 2026 and March 24, 2026, Defendants failed to disclose to investors that: (1) Defendant Soon-Shiong materially overstated Anktiva's capabilities; and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact: Howard G. Smith, Esq., Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Call us at: (215) 638-4847 Email us at: [email protected], Visit our website at: www.howardsmithlaw.com. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contact Us: Law Offices of Howard G. Smith Howard G. Smith, Esquire 215-638-4847 [email protected] www.howardsmithlaw.com SOURCE Law Offices of Howard G. Smith <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTIyJk5ld3NJdGVtSWQ9UEg2NjA4MyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MjIxMjAwUFJfTkVXU19VU1BSX19fX19QSDY2MDgz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTIyJk5ld3NJdGVtSWQ9UEg2NjA4MyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MjIxMjAwUFJfTkVXU19VU1BSX19fX19QSDY2MDgz"/></div> </div></div>

IBRX

SBIO

LABU

IBBQ

The Law Offices of Howard G. Smith announces that investors who suffered losses in ImmunityBio, Inc. (IBRX) have the opportunity to lead a securities fraud class action lawsuit. The complaint alleges that the company misled investors about Anktiva's capabilities between January 19, 2026, and March 24, 2026. Interested investors should contact the law firm before May 26, 2026, to participate.

prnewswire

ImmunityBio

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

Invesco Nasdaq Biotechnology ETF

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

iShares Biotechnology ETF

SPDR S&P Biotech

12:00 ETImmunityBio, Inc. (IBRX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit